Health
-
The Case for Vaccine Exemptions in Vermont -> Part 2
Despite alarmist claims, Vermont’s robust public health record shows no significant outbreaks tied to vaccine exemptions. While diseases like measles are eradicated and pertussis is…
-
The Case for Vaccine Exemptions in Vermont -> Part 1
Vermont’s long tradition of vaccine exemptions has sparked heated debate. Are exemptions really a public health threat, or do they reflect a balanced approach to…
-
Follow-Up: Medicare for All and the Real Cost Calculations
The true cost of Medicare for All isn’t just the $4.3 trillion needed annually—it’s the inevitable tax increases and service cuts as healthcare costs continue…
-
Bernie’s Medicare for All – A Fantasy That Defies Reality
Bernie Sanders’ Medicare for All promises affordability but defies economic reality. With Medicare facing insolvency by 2028, expanding this broken system would devastate take-home pay,…
-
Bernie, Heal Thyself
Bernie Sanders’ latest op-ed offers bold solutions like Medicare for All and price caps, but his focus on treating symptoms, not root causes, threatens to…
-
AHEAD: A New Health Care Experiment With Familiar Flaws
Vermont’s participation in the AHEAD model highlights its reliance on federal funding, but critics question whether this new initiative will solve systemic issues or repeat…
-
Are Sugary Cereals Healthier Than Steak? Food Compass Raises Eyebrows
Tufts’ Food Compass controversially ranks sugary cereals healthier than steak, sparking debates about modern dietary guidelines. Advocates of keto and low-carb lifestyles, like Dr. Eric…
-
Equal Pay, Unequal Costs: How Vermont Legislators Spent Your Money on H.861
Vermont’s H.861 mandates equal pay for in-person, telemedicine, and phone consultations, ignoring real cost differences and burdening taxpayers. While marketed as equitable, the law raises…
-
The Costly Trade-Off of Semaglutides: A Band-Aid for Obesity?
Semaglutides like Wegovy promise weight loss but mask deeper health issues. With soaring U.S. costs subsidizing global pricing and risks of chronic inflammation from poor…
-
PBMs: The Hidden Middlemen Driving Up Drug Prices
Pharmacy Benefit Managers (PBMs) control drug pricing through opaque practices like rebates and spread pricing, driving up costs for patients, taxpayers, and insurers. Reform is…
Signup Newsletter
By signing up, you agree to the our terms and our Privacy Policy agreement.
Subscribe to RSS
Make a Difference!
Contact FYIVT
Latest Posts
Latest Comments
Archives
- April 2026 (48)
- March 2026 (59)
- February 2026 (60)
- January 2026 (51)
- December 2025 (31)
- November 2025 (30)
- October 2025 (32)
- September 2025 (30)
- August 2025 (31)
- July 2025 (31)
- June 2025 (35)
- May 2025 (33)
- April 2025 (35)
- March 2025 (38)
- February 2025 (33)
- January 2025 (33)
- December 2024 (51)
- November 2024 (109)
- October 2024 (76)
- September 2024 (22)